Skip to main content
The FDA approval of pembrolizumab for patients with TMB >10 mut/Mb: was it a wise decision? No
Published Web Location
https://doi.org/10.1016/j.annonc.2020.07.001Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.